SUCCESSFUL LONG-TERM REMISSION IN AGGRESSIVE YOUNG-ONSET CHRONIC LYMPHOCYTIC LEUKEMIA WITH IBRUTINIB AND VENETOCLAX: A DECADE-LONG CASE STUDY
Chronic Lymphocytic Leukemia (CLL) typically affects older individuals and is frequently associated with genetic mutations that help predict its progression. However, this report presents a rare case of aggressive CLL in a young woman with no unfavorable genetic markers, who achieved lasting remissi...
Saved in:
| Main Authors: | Naciye Nur Tozluklu, Birol Guvenc |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Hematology, Transfusion and Cell Therapy |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2531137924028670 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Preventing and managing the toxicities associated with the combination therapy of ibrutinib and venetoclax in chronic lymphocytic leukaemia
by: Elżbieta Iskierka-Jażdżewska, et al.
Published: (2025-01-01) -
Ibrutinib in the Treatment of Refractory Chronic Lymphocytic Leukemia
by: EA Nikitin, et al.
Published: (2017-07-01) -
Venetoclax-Based Regimens in CLL: Immunoglobulin G Levels, Absolute Neutrophil Counts, and Infectious Complications
by: Wojciech Szlasa, et al.
Published: (2025-06-01) -
miR-155 and miR-223 as markers of biological and clinical features of chronic lymphocytic leukemia
by: M. L. Perepechaeva, et al.
Published: (2024-03-01) -
Treatment of relapsed/refractory CLL with Venetoclax-Rituximab during the COVID-19 pandemic: A daily-life experience in southern Italy.
by: Stefano Molica, et al.
Published: (2021-06-01)